Antiangiogenic Effect of Salvia officinalis
DOI:
https://doi.org/10.61841/fjj1qs40Keywords:
Medicinal Plants, Phytochemicals, Natural Compounds, Antiangiogenic ActivityAbstract
Angiogenesis plays a critical role in disease evolvement and exacerbations. This article has been prepared to evaluate the Antiangiogenic Effect of salvia officinalis that have been studied for their antiangiogenic activity. The plant sources of Iraq are likely to produce effective antiangiogenic substances. The phytochemical exploration of this plant has conferred to the discovery of new treatments for many disorders. Last year owing to the fear of adverse effects people favor the use of natural plant products for disease cure. This article also helps to summarize the different methodologies and various ways to evaluate the potential natural compounds having antiangiogenic action. The information collected here will take part in an essential role to develop new drug formulation for treatment angiogenesis-related diseases and further research should be done on the above mentioned plants.
Downloads
References
1. Zhang, X. (2000). General Guidelines for Methodologies on Research and Evaluation of Traditional Medicine. World Health Organization, Geneva, p. 1.
2. Carmeliet, P., & Jain, R. K. (2000). Angiogenesis in cancer and other diseases. Nature, 407(6801), 249.
3. Gordon, J. D., Shifren, J. L., Foulk, R. A., Taylor, R. N., & Jaffe, R. B. (1995). Angiogenesis in the human female reproductive tract. Obstetrical & Gynecological Survey, 50(9), 688–697.
4. Carmeliet, P. (2003). Angiogenesis in health and disease. Nature Medicine, 9(6), 653.
5. Folkman, J. (1971). Tumor angiogenesis: Therapeutic implications. New England Journal of Medicine, 285(21), 1182–1186.
6. Nishida, N., Yano, H., Nishida, T., Kamura, T., & Kojiro, M. (2006). Angiogenesis in cancer. Vascular Health and Risk Management, 2(3), 213.
7. Shoeb, M. (2006). Anti-cancer agents from medicinal plants. Bangladesh Journal of Pharmacology, 1(2), 35–41.
8. Malafronte, N., Vassallo, A., Dal Piaz, F., Bader, A., Braca, A., & De Tommasi, N. (2012). Bioflavonoids from Daphne linearifolia Hart. Phytochemistry Letters, 5(3), 621–625.
9. Khamees, A. H., Abdulhussein, A. J., Sahib, H. B., & Fawzi, H. A. (2018). Anti-angiogenic and antioxidant activity of Iraqi Cyperus rotundus ethanol extract. International Journal of Pharmacology, 14, 546–552.
10. Dinç, M., Pinar, N. M., Dogu, S., & Yildirim, S. (2009). Micromorphological studies of Lallemantia L. (Lamiaceae) species growing in Turkey. Acta Biologica Cracoviensia Series Botanica, 51, 45–54.
11. Walker, J. B., & Sytsma, K. J. (2007). Staminal evolution in the genus Salvia (Lamiaceae): Molecular phylogenetic evidence for multiple origins of the staminal lever. Annals of Botany, 100, 375–391.
12. Ulubelen, A. (2000). Chemical constituents: Terpenoids in the genus Salvia. In S. E. Kintzios (Ed.), Medicinal and Aromatic Plants—Industrial Profiles (Vol. 14, pp. 55–68). Harwood Academic, Reading, UK.
13. Hedge, I. C. (1972). Salvia L. In T. G. Tutin et al. (Eds.), Flora Europaea (Vol. 3, p. 188). Cambridge University Press, Cambridge, UK.
14. Šilić, Č. (1973). Atlas Drveća i Grmlja (Vol. 4, p. 174). Zavod za Izdavanje Udžbenika, Sarajevo, Bosnia and Herzegovina.
15. Herbalpedia. (2018). Sage. Available online (accessed 15 August 2018).
16. Noor, A., Lokman, S., & Elder, C. (2012). Chick chorioallantoic membrane (CAM) assay as an in vivo model to study the effect of newly identified molecules on ovarian cancer invasion and metastasis. International Journal of Molecular Sciences, 13(3), 9959–9970.
17. Clifford, J. (2001). Angiogenesis Protocols. University of Nottingham, UK, pp. 185–205.
18. Alper, G., Onural, Ö., Melek, K., & Engin, Ş. (2010). Radical scavenging activity and vitexin content of Vitex agnus-castus leaves and fruits. FABAD Journal of Pharmaceutical Sciences, 35(12), 85–89.
19. Domenico, R. (2010). The chick embryo chorioallantoic membrane as an in vivo assay to study antiangiogenesis. Pharmaceuticals, 3(1), 482–513.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
